What should you know about residual DCIS after lumpectomy?

A lumpectomy removes the visible breast abnormality with a surrounding rim of tissue. The pathology report checks whether DCIS reaches or comes close to that rim. A positive or close margin can mean that more DCIS may be left in the breast, although the report must be interpreted with the imaging and the operation details.

Residual DCIS is not automatically invasive breast cancer. The report may also describe grade, size, hormone receptors, and whether any invasive cells were seen. These findings help the team balance local treatment, breast preservation, and your preferences.

Meet with the breast surgeon to review the margin wording and the area still at concern. Depending on the findings, choices can include another lumpectomy to remove more tissue, mastectomy, or radiotherapy as part of breast-conserving care. Hormone treatment may be considered in some hormone-receptor-positive cases, while it does not replace surgery when tissue remains.

Take time to ask whether the original imaging matches the pathology and whether a specialist review is useful. Keep the pathology and operative reports available for every appointment.

After lumpectomy, report fever, spreading redness, increasing warmth, pus-like drainage, wound separation, or pain that is getting worse rather than settling. Seek urgent help for heavy bleeding, severe breathing difficulty, chest pain, or fainting. These are post-operative warning signs, not proof that the DCIS is invasive.

Ask which margin is involved, how much additional tissue may need removal, and whether the planned treatment aims to preserve the breast. Ask when radiotherapy would be used, what mastectomy would involve, and how follow-up imaging will be arranged.